Simethicone-cellulose
Sonorx (simethicone-cellulose) is a small molecule pharmaceutical. Simethicone-cellulose was first approved as Sonorx on 1998-10-29. It is used to treat flatulence in the USA.
Download report
Favorite
Top OTC Drugs
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Simethicone-cellulose
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SONORX | Bracco Diagnostics | N-020773 DISCN | 1998-10-29 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
43 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colonoscopy | D003113 | — | — | 1 | 4 | — | 5 | ||
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | 1 | 1 | 3 |
Colic | D003085 | HP_0011848 | R10.83 | — | 1 | — | 1 | 1 | 3 |
Diarrhea | D003967 | HP_0002014 | R19.7 | — | — | 1 | 1 | — | 2 |
Colonic neoplasms | D003110 | C18 | — | — | — | 1 | 1 | 2 | |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | 1 | — | 1 | |
Chronic renal insufficiency | D051436 | N18 | — | — | — | 1 | — | 1 | |
Colonic polyps | D003111 | K63.5 | — | — | — | 1 | — | 1 | |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | 1 | — | 1 |
Ileus | D045823 | K56.7 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 1 | — | 3 | 4 | ||
Female infertility | D007247 | EFO_0008560 | N97 | — | — | 1 | — | — | 1 |
Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach diseases | D013272 | — | 1 | — | — | 1 | 2 | ||
Otitis media | D010033 | EFO_0004992 | H66.9 | — | 1 | — | — | — | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | SIMETHICONE-CELLULOSE |
INN | — |
Description | Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O |
Identifiers
PDB | — |
CAS-ID | 8050-81-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1201493 |
ChEBI ID | — |
PubChem CID | 6433516 |
DrugBank | DB09512 |
UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,380 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more